Clinical Trial Update: Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of liraglutide on fatty liver content and lipoprotein metabolism in patients with type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Type 2 Diabetes | Phase 4 | Status: TERMINATED